No doubt that the aim of every pharmaceutical company and public, in general, is to have a strong, transparent and proactive pharmacovigilance system. Patient safety depends not only on safe products but also on the appropriate use of these products after they are approved for the market. That is why the right risk communication to the public is crucial. The world is moving quickly and so is pharmacovigilance – new technologies and trends are coming with many benefits but threats as well. The pharmaceutical industry has now a clear goal – to understand the patient and to have individual approach to the patients – this is reflected in pharmacovigilance as well.
The 7th Annual Risk Management and Pharmacovigilance Summit will be the right place to meet the best pharmacovigilance experts from the top pharma companies worldwide, who will share their know-how and latest case studies. All the pharmaceutical professionals are invited to join this business conference and learn the newest trends in pharmacovigilance. The main topics of this international pharmaceutical meeting are proactive safety, inspection readiness, counterfeiting of pharmaceutical products, digitalisation, and social media, safety evaluation, the increasing requirements for QPPVs and many others.
This exclusive risk management and pharmacovigilance event will definitely provide you with lessons learned and give you valuable tips shared by senior-level decision-makers. You will also benefit from remarkable networking opportunities due to limited seats of this business meeting. Do not hesitate and book the dates 9-11 September 2020 for this inspiring risk management and pharmacovigilance conference in Vienna!
Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from pharmaceutical industry involved in: